![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|17|7|771-776
ISSN: 1389-4501
Source: Current Drug Targets, Vol.17, Iss.7, 2016-06, pp. : 771-776
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for renal cell carcinoma
By Varella Leticia Rini Brian I
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for renal cell carcinoma
By Shaheen Philip E Bukowski Ronald M
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Axitinib for the Management of Metastatic Renal Cell Carcinoma
Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?
By Pal Sumanta K. Figlin Robert A.
Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. :